Legal Representation
Attorney
Lisa L. Mueller
USPTO Deadlines
Next Deadline
1239 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-13)
Due Date
December 13, 2028
Grace Period Ends
June 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 13, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 13, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 13, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 27, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 27, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 7, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 18, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 17, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 17, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 17, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 17, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 17, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 21, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 21, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jul 21, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 14, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 13, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 13, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 27, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 15, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 14, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for human use, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders; biological preparations for medical and therapeutic purposes, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
044